We found that RACGAP1 silencing markedly reduced the expression of CPT1A in breast cancer cell lines (Fig. 5A), while RACGAP1 overexpression enhanced the CPT1A expression (Fig. 5B). This evidence concerns the gene CPT1A and breast cancer.